“You have to come because
you are passionate about the discovery of new
drugs and because you are passionate about translating fundamental
science into
something useful. Someone who can see those
kinds of possibilities will do well in industry,” says Paul. “If you
want to just
pursue pure fundamental research, however, this
is probably not the best environment. I have seen very fine academics
come
to industry and struggle because of this. But if
you want to discover a drug for a major disease, like schizophrenia or
Alzheimer's
disease, this could well be the best place for
you.”
Find the full article here.
No comments:
Post a Comment